Alvotech (ALVO)
USD 8.33
(0.48%)
USD 8.33
(0.48%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -484.86 Million USD | -2.63% |
| 2022 | -439.8 Million USD | -93.96% |
| 2021 | 3.99 Million USD | -33.77% |
| 2020 | -125.67 Million USD | -161.2% |
| 2019 | -99.02 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -65.69 Million USD | 75.7% |
| 2024 Q2 | -45.84 Million USD | 51.06% |
| 2023 Q2 | -86.95 Million USD | 4.84% |
| 2023 Q1 | -91.37 Million USD | 51.05% |
| 2023 FY | - USD | -2.63% |
| 2023 Q3 | -39.5 Million USD | 54.57% |
| 2023 Q4 | -116.81 Million USD | -195.72% |
| 2022 Q1 | -68.35 Million USD | -506.8% |
| 2022 FY | - USD | -93.96% |
| 2022 Q4 | -186.67 Million USD | -502.89% |
| 2022 Q3 | 46.33 Million USD | 134.84% |
| 2022 Q2 | -132.98 Million USD | -94.57% |
| 2021 FY | - USD | -33.77% |
| 2021 Q2 | -573.8 Thousand USD | -5.18% |
| 2021 Q3 | -70.17 Million USD | -12129.17% |
| 2021 Q4 | 16.8 Million USD | 123.94% |
| 2021 Q1 | -545.56 Thousand USD | -131.83% |
| 2020 FY | - USD | -161.2% |
| 2020 Q4 | -235.33 Thousand USD | 99.52% |
| 2020 Q3 | -48.57 Million USD | 0.0% |
| 2020 Q2 | -48.57 Million USD | 0.0% |
| 2020 Q1 | -48.57 Million USD | -71.0% |
| 2019 Q1 | -28.4 Million USD | 0.0% |
| 2019 Q2 | -28.4 Million USD | 0.0% |
| 2019 Q3 | -28.4 Million USD | 0.0% |
| 2019 Q4 | -28.4 Million USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Journey Medical Corporation | 1.92 Million USD | 25340.083% |
| Safety Shot Inc | -12.18 Million USD | -3879.111% |
| Bright Green Corporation | - USD | Infinity% |
| Aquestive Therapeutics, Inc. | 1.18 Million USD | 41120.474% |
| Cosmos Health Inc. | -17.06 Million USD | -2741.799% |
| Dynavax Technologies Corporation | 9.66 Million USD | 5116.16% |
| Embecta Corp. | 245.4 Million USD | 297.58% |
| Esperion Therapeutics, Inc. | -150.1 Million USD | -223.009% |
| Intra-Cellular Therapies, Inc. | -158.85 Million USD | -205.227% |
| Pacira BioSciences, Inc. | 162.89 Million USD | 397.649% |
| PainReform Ltd. | -9.56 Million USD | -4967.008% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -12578.06% |
| SCYNEXIS, Inc. | 73.47 Million USD | 759.865% |
| China SXT Pharmaceuticals, Inc. | -2.35 Million USD | -20523.562% |
| Alpha Teknova, Inc. | -25.53 Million USD | -1798.516% |
| ANI Pharmaceuticals, Inc. | 109.32 Million USD | 543.525% |
| Collegium Pharmaceutical, Inc. | 308.32 Million USD | 257.255% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -12578.06% |
| Procaps Group, S.A. | 104.02 Million USD | 566.092% |
| Theratechnologies Inc. | -10.31 Million USD | -4601.556% |
| Harrow Health, Inc. | 9.72 Million USD | 5086.753% |
| Sonoma Pharmaceuticals, Inc. | -4.52 Million USD | -10615.182% |
| Biofrontera Inc. | -18.45 Million USD | -2527.551% |
| DURECT Corporation | -24.68 Million USD | -1864.276% |
| Supernus Pharmaceuticals, Inc. | 98.26 Million USD | 593.438% |
| Cronos Group Inc. | -72.14 Million USD | -572.029% |
| OptiNose, Inc. | -15.55 Million USD | -3017.482% |
| Ironwood Pharmaceuticals, Inc. | -924.86 Million USD | 47.575% |
| Kala Pharmaceuticals, Inc. | -36.08 Million USD | -1243.778% |
| RedHill Biopharma Ltd. | 26.26 Million USD | 1945.958% |
| Organogenesis Holdings Inc. | 36.03 Million USD | 1445.68% |
| Guardion Health Sciences, Inc. | -3.92 Million USD | -12261.505% |
| Cumberland Pharmaceuticals Inc. | -710.85 Thousand USD | -68108.764% |
| Radius Health, Inc. | 38.31 Million USD | 1365.628% |
| Universe Pharmaceuticals INC | -3.21 Million USD | -14980.921% |
| ProPhase Labs, Inc. | -14.82 Million USD | -3170.129% |
| Phibro Animal Health Corporation | 84.6 Million USD | 673.076% |
| Procaps Group S.A. | 104.02 Million USD | 566.092% |
| TherapeuticsMD, Inc. | -8.4 Million USD | -5671.48% |
| Viatris Inc. | 3.51 Billion USD | 113.788% |
| Rockwell Medical, Inc. | -4.69 Million USD | -10229.399% |
| Aytu BioPharma, Inc. | -1.01 Million USD | -47811.265% |
| SIGA Technologies, Inc. | 84.15 Million USD | 676.123% |
| Tilray Brands, Inc. | -72.84 Million USD | -565.626% |
| Lifecore Biomedical, Inc. | 812 Thousand USD | 59812.069% |
| Shineco, Inc. | -26.55 Million USD | -1725.953% |
| PetIQ, Inc. | 81.48 Million USD | 695.025% |
| Regencell Bioscience Holdings Limited | -3.61 Million USD | -13302.76% |
| Incannex Healthcare Limited | -18.5 Million USD | -2520.309% |
| Neurocrine Biosciences, Inc. | 416.1 Million USD | 216.525% |
| Alimera Sciences, Inc. | 7.27 Million USD | 6763.854% |
| Silver Spike Investment Corp. | 7.34 Million USD | 6705.65% |
| Assertio Holdings, Inc. | -222.44 Million USD | -117.967% |
| Shuttle Pharmaceuticals Holdings, Inc. | -3.99 Million USD | -12049.954% |
| Petros Pharmaceuticals, Inc. | -4.21 Million USD | -11411.796% |
| Clever Leaves Holdings Inc. | -16.8 Million USD | -2785.396% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | -2320.585% |
| Avadel Pharmaceuticals plc | -149.12 Million USD | -225.138% |
| Hempacco Co., Inc. | -12.77 Million USD | -3695.912% |
| Talphera, Inc. | -9.84 Million USD | -4826.458% |
| Alvotech | -484.86 Million USD | -0.0% |
| Eagle Pharmaceuticals, Inc. | 77.5 Million USD | 725.612% |
| Lantheus Holdings, Inc. | 491 Million USD | 198.749% |
| Currenc Group, Inc. | -1.9 Million USD | -25411.346% |
| Kamada Ltd. | 21.53 Million USD | 2351.611% |
| Indivior PLC | 66 Million USD | 834.639% |
| Evoke Pharma, Inc. | -7.29 Million USD | -6548.963% |
| Flora Growth Corp. | -45.87 Million USD | -957.035% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | -2320.585% |
| Evolus, Inc. | -41.81 Million USD | -1059.68% |
| HUTCHMED (China) Limited | 25.52 Million USD | 1999.334% |
| Amphastar Pharmaceuticals, Inc. | 241.46 Million USD | 300.801% |
| Akanda Corp. | -27.73 Million USD | -1648.152% |